The detection of Myositis specific autoantibodies (MSAs) is essential in the diagnosis of autoimmune myositis. MSAs are directed against cytoplasmic or nuclear components involved in key regulatory intracellular processes including protein synthesis, translocation and gene transcription. The striking association between unique serological profiles and distinct clinical phenotypes suggests that target autoantigens may play a role in disease induction and propagation.
